ZANARDI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 1.409
Totale 1.409
Nazione #
IT - Italia 1.409
Totale 1.409
Città #
Genova 790
Rapallo 369
Genoa 218
Bordighera 32
Totale 1.409
Nome #
Targeting androgen-independent pathways: new chances for patients with prostate cancer?, file e268c4c9-aab9-a6b7-e053-3a05fe0adea1 263
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer, file e268c4ca-737e-a6b7-e053-3a05fe0adea1 183
Better Together: Immunotherapy as Future Combination Strategy for Breast Cancer, file e268c4cb-b01f-a6b7-e053-3a05fe0adea1 110
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes, file e268c4c8-60ad-a6b7-e053-3a05fe0adea1 108
Better Together: Targeted Combination Therapies in Breast Cancer, file e268c4cb-cf66-a6b7-e053-3a05fe0adea1 104
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer, file e268c4ca-9c21-a6b7-e053-3a05fe0adea1 90
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients, file e268c4ca-8aca-a6b7-e053-3a05fe0adea1 89
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa), file e268c4ca-1dbe-a6b7-e053-3a05fe0adea1 69
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223, file e268c4cb-c830-a6b7-e053-3a05fe0adea1 60
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone, file e268c4ca-2cb5-a6b7-e053-3a05fe0adea1 57
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives, file e268c4ce-b84b-a6b7-e053-3a05fe0adea1 53
Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer, file e268c4cb-b83e-a6b7-e053-3a05fe0adea1 48
null, file e268c4cc-f342-a6b7-e053-3a05fe0adea1 42
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma, file e268c4cb-9f00-a6b7-e053-3a05fe0adea1 36
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature, file e268c4cb-cf67-a6b7-e053-3a05fe0adea1 13
Combination therapy in metastatic renal cell carcinoma: Back to the future?, file e268c4cc-efda-a6b7-e053-3a05fe0adea1 12
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223, file e268c4ce-4e49-a6b7-e053-3a05fe0adea1 12
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications, file e268c4cd-6429-a6b7-e053-3a05fe0adea1 9
Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype, file e268c4cc-68ea-a6b7-e053-3a05fe0adea1 5
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer, file e268c4cc-beee-a6b7-e053-3a05fe0adea1 5
A Case of Plasmacytoid Variant of Bladder Cancer with a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature, file e268c4ca-5800-a6b7-e053-3a05fe0adea1 3
May adjuvant therapy play a role for the management of renal cell carcinoma? A review of literature and ongoing trials, file e268c4ca-7906-a6b7-e053-3a05fe0adea1 3
861P Time to castration resistant prostate cancer (CRPC) and the risk of developing immune disorders, file e268c4cb-a7f8-a6b7-e053-3a05fe0adea1 3
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study, file e268c4cb-fb90-a6b7-e053-3a05fe0adea1 3
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients, file 5b8b7099-858d-4628-9313-9e2cd0bfb031 2
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial, file e268c4c6-cbe2-a6b7-e053-3a05fe0adea1 2
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens., file e268c4c6-cfdd-a6b7-e053-3a05fe0adea1 2
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study, file e268c4c9-08b4-a6b7-e053-3a05fe0adea1 2
Treatment of elderly patients with metastatic renal cell carcinoma, file e268c4ca-6d00-a6b7-e053-3a05fe0adea1 2
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey, file e268c4cb-8dd7-a6b7-e053-3a05fe0adea1 2
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer, file e268c4cb-9e90-a6b7-e053-3a05fe0adea1 2
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes, file e268c4cb-fb93-a6b7-e053-3a05fe0adea1 2
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS), file e268c4cb-fb96-a6b7-e053-3a05fe0adea1 2
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer, file e268c4cc-ff86-a6b7-e053-3a05fe0adea1 2
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial, file e268c4cd-b9d5-a6b7-e053-3a05fe0adea1 2
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens., file e268c4c7-1ed7-a6b7-e053-3a05fe0adea1 1
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer, file e268c4c8-5c6d-a6b7-e053-3a05fe0adea1 1
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome, file e268c4ca-6735-a6b7-e053-3a05fe0adea1 1
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials, file e268c4ca-6cfb-a6b7-e053-3a05fe0adea1 1
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience, file e268c4ca-dbc8-a6b7-e053-3a05fe0adea1 1
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study, file e268c4cc-36aa-a6b7-e053-3a05fe0adea1 1
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management, file e80fafa5-e885-4b09-9d10-4f6342006d21 1
Totale 1.409
Categoria #
all - tutte 3.322
article - articoli 3.319
book - libri 0
conference - conferenze 3
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020114 2 0 0 1 11 16 13 12 19 15 14 11
2020/2021256 10 20 10 24 6 14 22 37 20 43 28 22
2021/2022433 28 16 24 59 40 12 13 7 49 27 110 48
2022/2023436 20 17 76 73 29 80 27 11 15 44 36 8
2023/2024166 3 9 11 10 17 15 39 45 5 12 0 0
Totale 1.409